Monday 15 October 2012

DMD: Reformulated Utrophin Upregulator Looks Good in Healthy Volunteers | Quest Magazine Online

DMD: Reformulated Utrophin Upregulator Looks Good in Healthy Volunteers | Quest Magazine Online: Summit PLC, a drug discovery company based in Oxford, U.K., has announced that SMT C1100, its experimental oral drug for Duchenne muscular dystrophy (DMD), appears safe and well-tolerated in healthy volunteers at all doses tested, and that it reaches levels in the bloodstream believed to be adequate for a therapeutic benefit.

No comments:

Post a Comment